Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery

References

• WHO world health organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. WHO. Available from: http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/. Published 2017 Accessed 625, 2019.
   Google Scholar
• Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31(4):707–721. doi:10.1185/03007995.2015.101898925697677
   PubMed Web of Science ®Google Scholar
• Sierra JM, Fusté E, Rabanal F, Vinuesa T, Viñas M. An overview of antimicrobial peptides and the latest advances in their development. Expert Opin Biol Ther. 2017;17(6):663–676. doi:10.1080/14712598.2017.131540228368216
   PubMed Web of Science ®Google Scholar
• Trimble MJ, Mlynárčik P, Kolář M, Hancock REWW. Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(10):cshperspect.a025288. doi:10.1101/cshperspect.a025288
   Web of Science ®Google Scholar
• Karaiskos I, Souli M, Galani I, Giamarellou H. Colistin: still a lifesaver for the 21st century? Expert Opin Drug Metab Toxicol. 2017;13(1):59–71. doi:10.1080/17425255.2017.123020027573251
   PubMed Web of Science ®Google Scholar
• Lim LM, Ly N, Anderson D, et al. Resurgence of colistin: A review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy. 2010;30(12):1279–1291. doi:10.1592/phco.30.12.127921114395
   PubMed Web of Science ®Google Scholar
• Srinivas P, Rivard K. Polymyxin resistance in Gram-negative pathogens. Curr Infect Dis Rep. 2017;19(11):38. doi:10.1007/s11908-017-0596-328895051
   PubMed Web of Science ®Google Scholar
• Lenhard JR, Nation RL, Tsuji BT. Synergistic combinations of polymyxins. Int J Antimicrob Agents. 2016;48(6):607–613. doi:10.1016/j.ijantimicag.2016.09.01427865626
   PubMed Web of Science ®Google Scholar
• Yang H, Chen G, Hu L, et al. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae : in vitro activity and a Galleria mellonella model. J Microbiol Immunol Infect. 2018;51(1):70–75. doi:10.1016/j.jmii.2016.01.00326906264
   PubMedGoogle Scholar
• D’Souza BB, Padmaraj SR, Rekha PD, Tellis RC, Prabhu S, Pothen P. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa. Microb Drug Resist. 2014;20(6):550–554. doi:10.1089/mdr.2014.000625055029
   PubMed Web of Science ®Google Scholar
• Rudilla H, Pérez-Guillén I, Rabanal F, Sierra JM, Vinuesa T, Viñas M. Novel synthetic polymyxins kill Gram-positive bacteria. J Antimicrob Chemother. 2018;73(12):3385–3390. doi:10.1093/jac/dky36630215733
   PubMed Web of Science ®Google Scholar
• Ni W, Shao X, Di X, Cui J, Wang R, Liu Y. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Int J Antimicrob Agents. 2015;45(1):8–18. doi:10.1016/j.ijantimicag.2014.10.00225465524
   PubMed Web of Science ®Google Scholar
• Liu B, Liu Y, Di X, et al. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii. Rev Soc Bras Med Trop. 2014;47(4):451–456. doi:10.1590/0037-8682-0081-201425229285
   PubMed Web of Science ®Google Scholar
• Hornsey M, Wareham DW. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2011;55(7):3534–3537. doi:10.1128/AAC.00230-1121502628
   PubMed Web of Science ®Google Scholar
• Rudilla H, Fusté E, Cajal Y, Rabanal F, Vinuesa T, Viñas M. Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems. Molecules. 2016;21(9):1223. doi:10.3390/molecules21091223
   PubMed Web of Science ®Google Scholar
• Abdul Rahim N, Cheah S-E, Johnson MD, et al. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two “old” antibiotics-polymyxin B and chloramphenicol. J Antimicrob Chemother. 2015;70(9):2589–2597. doi:10.1093/jac/dkv13526023209
   PubMed Web of Science ®Google Scholar
• Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol. 1995;16(1):45–55. doi:10.1111/j.1365-2958.1995.tb02390.x7651136
   PubMed Web of Science ®Google Scholar
• Sánchez L, Pan W, Viñas M, Nikaido H. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J Bacteriol. 1997;179(21):6855–6857. doi:10.1128/jb.179.21.6855-6857.19979352940
   PubMed Web of Science ®Google Scholar
• Renau TE, Léger R, Flamme EM, et al. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem. 1999;42(24):4928–4931. doi:10.1021/jm990459810585202
   PubMed Web of Science ®Google Scholar
• EUCAST. European committee on antimicrobial susceptibility testing breakpoint tables for interpretation of MICs and zone diameters version 6.0, valid from 2016-01-01. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.xlsx. Accessed January, 2019.
   Google Scholar
• Mykytczuk NCS, Trevors JT, Leduc LG, Ferroni GD. Fluorescence polarization in studies of bacterial cytoplasmic membrane fluidity under environmental stress. Prog Biophys Mol Biol. 2007;95(1–3):60–82. doi:10.1016/j.pbiomolbio.2007.05.00117628643
   PubMed Web of Science ®Google Scholar
• Martins A, Amaral L. Screening for efflux pump systems of bacteria by the new acridine orange agar method. In Vivo (Brooklyn). 2012;26(2):203–206.
   Web of Science ®Google Scholar
• Richter MF, Drown BS, Riley AP, et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 2017;545(7654):299–304. doi:10.1038/nature2230828489819
   PubMed Web of Science ®Google Scholar
• Eze MO, McElhaney RN. The effect of alterations in the fluidity and phase state of the membrane lipids on the passive permeation and facilitated diffusion of glycerol in Escherichia coli. J Gen Microbiol. 1981;124(2):299–307. doi:10.1099/00221287-124-2-2997035612
   PubMedGoogle Scholar
• Vincent M, England LS, Trevors JT. Cytoplasmic membrane polarization in Gram-positive and Gram-negative bacteria grown in the absence and presence of tetracycline. Biochim Biophys Acta - Gen Subj. 2004;1672(3):131–134. doi:10.1016/j.bbagen.2004.03.005
   Web of Science ®Google Scholar
• Wareham DW, Gordon NC, Hornsey M. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother. 2011;66(5):1047–1051. doi:10.1093/jac/dkr06921393131
   PubMed Web of Science ®Google Scholar
• Brennan-Krohn T, Pironti A, Kirby JE. Synergistic activity of colistin-containing combinations against colistin-resistant enterobacteriaceae. Antimicrob Agents Chemother. 2018;62(10):AAC.00873–18. doi:10.1128/AAC.00873-18
   Web of Science ®Google Scholar
• Li Y, Lin X, Yao X, et al. Synergistic antimicrobial activity of colistin in combination with rifampin and azithromycin against Escherichia coli producing MCR-1. Antimicrob Agents Chemother. 2018;62(12):e1631–e18. doi:10.1128/AAC.01631-18
   Web of Science ®Google Scholar